This service provides screening of novel psychoactive compounds for pharmacological and functional activity at cloned human or rodent CNS receptors, channels, and transporters. Pharmacological and functional screening of novel compounds is provided as a contractor to NIMH. Screening of compounds is provided to qualified academic investigators at no cost.